From: WSES/GAIS/SIS-E/WSIS/AAST global clinical pathways for patients with intra-abdominal infections
Vasopressor | Receptor activity | Dose (all intravenous) |
---|---|---|
Norepinephrine | α1 > β1, β2 | 5–100 μg/min |
Epinephrine | α1 > β1, β2 More β1 than NE | 5–60 μg/kg min |
Phenylephrine | α1 | 50–100 μg bolus 0.1–1.5 μg/kg/min |
Dopamine | DA1, DA2 | 1–5 μg/kg/min “low dose” 5–15 μg/kg/min moderate dose 20–50 μg/kg min high dose |
Vasopressin | AVPR1a, AVPR1b, AVPR2 | 0.01–0.04 U/min |